A study on the association of TNF-α-308, IL-6-174, IL-10-1082 and IL-1RaVNTR gene polymorphisms with rheumatic heart disease in Pakistani patients

Cytokine

Volumn 61, Issue 2, 2013, Pages 527-531

  Rehman, Sadia ^a   Akhtar, Naveed ^b   Saba, Nusrat ^a   Munir, Saeeda ^a   Ahmed, Waqar ^c   Mohyuddin, Aisha ^b   Khanum, Azra ^d  

^a INSTITUTE OF BIOMEDICAL AND GENETIC ENGINEERING IBGE   (Pakistan)

^b SHIFA COLLEGE OF MEDICINE   (Pakistan)

^c National University of Medical Sciences   (Pakistan)

^d PMAS ARID AGRICULTURE UNIVERSITY   (Pakistan)

Author keywords

Cytokines; Genetic association; Genetic polymorphisms; Rheumatic heart disease

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; DNA POLYMORPHISM; ETHNICITY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PAKISTANI; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RHEUMATIC HEART DISEASE; VARIABLE NUMBER OF TANDEM REPEAT;

ADULT; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MINISATELLITE REPEATS; PAKISTAN; POLYMORPHISM, GENETIC; RHEUMATIC HEART DISEASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84873141552     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.10.020     Document Type: Article

References (41)

1. Sadiq M., Islam K., Abid R., Latif F., Rehman A.U., Waheed A., et al. Prevalence of rheumatic heart disease in school children of urban Lahore. Heart 2009, 95:353-357.
2. Rizvi S.F., Khan M.A., Kundi A., Marsh D.R., Samad A., Pasha O. Status of rheumatic heart disease in rural Pakistan. Heart 2004, 90:394-399.
3. Guilherme L., Ramasawamy R., Kalil J. Rheumatic heart disease; genetics and pathogenesis. Scand J Immunol 2007, 66:199-207.
4. Guilherme L., Kalil J. Rheumatic fever and rheumatic heart disease: cellular mechanisms leading autoimmune reactivity and disease. J Clin Immunol 2010, 30:17-23.
5. Wilson A.G., Symons J.A., McDowell T.L., McDevitt H.O., Duff G.W. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci. USA 1997, 94:3195-3199.
6. Elahi M.M., Asotra K., Matata B.M., Mastana S.S. Tumor necrosis factor alpha -308 gene locus promoter polymorphism: an analysis of association with health and disease. Biochim Biophys Acta 2009, 1792:163-172.
7. Miller L.C., Gray E.D., Mansour M., Abdin Z.H., Kamel R., Zaher S., et al. Cytokines and immunoglobulin in rheumatic heart disease: production by blood and tonsillar mononuclear cells. J Rheumatol 1989, 16:1436-1442.
8. Guilherme L., Cury P., Demarchi L.M., Coelho V., Abel L., Lopez A.P., et al. Rheumatic heart disease: proinflammatory cytokines play a role in the progression and maintenance of valvular lesions. Am J Pathol 2004, 165:1583-1591.
9. Humphries S.E., Luong L.A., Ogg M.S., Hawe E., Miller G.J. The Interleukin-6 - 174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J 2001, 22:2243-2252.
10. Maitra A., Shanker J., Dash D., John S., Sannappa P.R., Rao V.S., et al. Polymorphisms in the IL6 gene in Asian Indian families with premature coronary artery disease - the Indian Atherosclerosis research study. Thromb. Haemost. 2008, 99:944-950.
11. Sie M.P., Mattace-Raso F.U., Uitterlinden A.G., Arp P.P., Hofman A., Pols H.A., et al. The Interleukin-6 -174 G/C promoter polymorphism and arterial stiffness; the rotterdam study. Vasc Health Risk Manage 2008, 4:863-869.
12. Tonet A.C., Karnikowski M., Moraes C.F., Gomes L., Karnikowski M.G., Córdova C., et al. Association between- 174 G/C promoter polymorphism of the Interleukin-6 gene and cardiovascular disease risk factors in Brazilian older women. Braz J Med Biol Res 2008, 41:47-53.
13. -174 and IL-RaVNTR related to susceptibility and severity of rheumatic heart disease. Pediatr Cardiol 2007, 28:363-371.
14. Fishman D., Faulds G., Jeffery R., Mohammed-Ali V., Yudkins J.S., Humphries S., et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998, 102:1369-1376.
15. Turner D.M., Williams D.M., Sankaran D., Lazarus M., Sinnott P.J., Hutchinson I.V. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997, 24:1-8.
16. Cavet J., Middleton P.G., Segall M., Noreen H., Davies S.M., Dickinson A.M. Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants. Blood 1999, 94:3941-3946.
17. Lee Y.H., Bae S.C., Choi S.J., Ji J.D., Song G.G. Associations between interleukin-10 polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis. Mol Biol Rep 2012, 39:81-87.
18. Wang Y., Zheng J., Liu P., Yu X., Zhou D., Jiang L., et al. Association between the Interleukin 10-1082 G > A polymorphism and coronary heart disease risk in a Caucasian population: a meta-analysis. Int J Immunogenet 2012, 39:144-150.
19. Tarlow J.K., Blakemore A.I.F., Lennard A., Solari R., Hughes H.N., Steinkasserer A., et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86 bp tandem repeat. Hum Genet 1993, 91:403-404.
20. Vamvakopoulos J.E., Taylor C.J., Morris-Stiff G.J., Green C., Metcalfe S. The interleukin-1 receptor antagonist gene: a single-copy variant of the intron 2 variable number tandem repeat (VNTR) polymorphism. Eur J Immunogenet 2002, 29:337-340.
21. Witkin S.S., Gerber S., Ledger W.J. Influence of Interleukin-1 receptor antagonist gene polymorphism on disease. Clin Infect Dis 2002, 34:204-209.
22. Braunwald E., Zipes D.P., Libby P. Heart Disease: A text book of Cardiovascular Medicine 2001, WB Saunders Company, Philadelphia. 6th ed.
23. Sambrook J., Russel D.W. Molecular cloning: A Laboratory Manual 2001, Cold Spring Harbor Laboratory Press, New York. 3rd ed.
24. L. Excoffier, G. Laval, S. Schneider, Arlequin ver. 3.0: an integrated software package for population genetics data analysis, Evolutionary Bioinformatics Online 1 (2005) 47-50. http://cmpg.unibe.ch/software/arlequin3.
25. J. C. Pezzullo, (accessed 22/05/2010). http://statpages.org/ctab2x2.html.
26. Carapetis J.R., Steer A.C., Mulholland E.K., Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis 2005, 5:685-694.
27. Steer A.C., Carapetis J.R. Prevention and treatment of rheumatic heart disease in the developing world. Nat Rev Cardiol 2009, 6:689-698.
28. Bittles A.H. Population stratification and genetic association studies in South Asia. J Mol Genet Med 2005, 1:43-48.
29. Hernández-Pacheco G., Flores-Domínguez C., Rodríguez-Pérez J.M., Pérez-Hernández N., Fragoso J.M., Saul A., et al. Tumor necrosis factor alpha promoter polymorphisms in Mexican patients with rheumatic heart disease. J. Autoimmun. 2003, 21:59-63.
30. Sallakci N., Akcurin G., Köksoy S., Kardelen F., Uguz A., Coskun M., et al. TNF-alpha G-308A polymorphism is associated with rheumatic fever and correlates with increased TNF-alpha production. J Autoimmun 2005, 25:150-154.
31. Ramasawmy R., Faé K.C., Spina G., Victora G.D., Tanaka A.C., Palácios S.A., et al. Association of polymorphisms within the promoter region of the tumor necrosis factor-alpha with clinical outcomes of rheumatic fever. Mol Immunol 2007, 44:1873-1878.
32. Mekinian A., Tamouza R., Pavy S., Gestermann N., Ittah M., Mariette X., et al. Functional study of TNF-α promoter polymorphisms: literature review and meta-analysis. Eur Cytokine Netw 2011, 22:88-102.
33. Pociot F., Briant L., Jongeneel C.V., Mölvig J., Worsaae H., Abbal M., et al. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol 1993, 23:224-231.
34. Rehman S., Akhtar N., Ahmed W., Ayub Q., Mehdi S.Q., Mohyuddin A. Human leukocyte antigen (HLA) class II association with rheumatic heart disease in Pakistan. J Heart Valve Dis 2007, 16:300-304.
35. Imanishi T., Akaza T., Kimura A., Tokunaga K., Gojobori T. Estimation of allele and haplotype frequencies for HLA and complement loci. HLA1991 1992, 76-79. Oxford University Press, Oxford. K. Tsuji, M. Aizawa, T. Sasazuki (Eds.).
36. Nauck M., Winkelmann B.R., Hoffmann M.M., Böhm B.O., Wieland H., März W. The interleukin-6 G(-174)C promoter polymorphism in the LURIC cohort: no association with plasma interleukin-6, coronary artery disease, and myocardial infarction. J Mol Med 2002, 80:507-513.
37. Col-Araz N., Pehlivan S., Baspinar O., Oguzkan-Balci S., Sever T., Balat A., et al. Role of cytokine gene (IFN-γ, TNF-α, TGF-β1, IL-6 and IL-10) polymorphisms in pathogenesis of acute rheumatic fever in Turkish children. Eur J Pediatr 2012, 171.
38. Chou H.T., Tsai C.H., Chen W.C., Tsai F.J. Lack of association of genetic polymorphisms in the interleukin-1beta, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 genes with risk of rheumatic heart disease in Taiwan Chinese. Int Heart J 2005, 46:397-406.
39. Bid H.K., Kumar A., Mishra P.K., Mittal R.D. Study of interleukin-1 receptor antagonist (IL-Ra) gene polymorphism in healthy individuals from Northern India. Indian J Clin Biochem 2004, 19:119-123.
40. Pyo C.W., Hur S.S., Kim Y.K., Choi H.B., Hong Y.S., Kim D.W., et al. Polymorphisms of IL-1B, IL-1RN, IL-2, IL-4, IL-6, IL-10 and IF-γ genes in the Korean population. Hum Immunol 2003, 64:979-989.
41. Azevedo P.M., Bauer R., Caparbo Vde F., Silva C.A., Bonfá E., Pereira R.M. Interleukin-1 receptor antagonist gene (IL1RN) polymorphism possibly associated to severity of rheumatic carditis in a Brazilian cohort. Cytokine 2010, 49:109-113.